Filing Flows › Cronos Group (CRON) › Q3 2026 › vs Q2 2026
Cronos Group (CRON) Q3 2026 vs Q2 2026 (quarter over quarter)
Cronos Group's revenue rose $13.3M (+19%) from $70.6M in Q2 2026 to $83.9M in Q3 2026. The biggest changes: Cannabis flower +$8.8M (+22%); Other revenues +$2.9M (+16%); Cannabis extracts +$1.7M (+12%). Gross margin 38.5% against 40.3% (-1.8 pts).
Cronos Group, Q3 2026: revenue $83.9M (+72% year over year), operating margin 10.8%, net earnings $13.8M, operating cash flow $34.3M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 38.5% | 40.3% | -1.8 pts |
| Operating margin | 10.8% | 10.5% | +0.3 pts |
| Net margin | 16.5% | 45.4% | -29.0 pts |
| Free cash flow margin | 29.1% | 31.5% | -2.5 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Cannabis flower | $48.0M | $39.2M | $8.8M | +22% |
| Cannabis extracts | $15.5M | $13.8M | $1.7M | +12% |
| Other revenues | $20.5M | $17.6M | $2.9M | +16% |
| Revenue | $83.9M | $70.6M | $13.3M | +19% |
| Gross profit | $32.3M | $28.5M | $3.8M | +13% |
| Cost of revenue | $51.6M | $42.1M | $9.5M | +22% |
| Other income, net | $9.7M | $28.3M | −$18.6M | -66% |
| Operating profit | $9.0M | $7.4M | $1.6M | +22% |
| Operating expenses | $23.3M | $21.0M | $2.2M | +11% |
| Pre-tax earnings | $18.7M | $35.7M | −$17.0M | -48% |
| Research & development | $1.3M | $1.2M | $121K | +10% |
| Sales & marketing | $7.1M | $6.8M | $352K | +5% |
| General & admin | $12.0M | $10.8M | $1.2M | +11% |
| Other operating costs | $2.8M | $2.2M | $540K | +24% |
| Net earnings | $13.8M | $32.1M | −$18.3M | -57% |
| Minority interests | $4.0M | $3.6M | $444K | +12% |
| Income tax | $898K | $51K | $847K | 18× |
| Depreciation & amortization | $4.7M | $3.4M | $1.3M | +40% |
| Share-based compensation | $2.3M | $1.6M | $753K | +48% |
| Working capital & other | $13.5M | −$13.0M | $26.5M | — |
| Operating cash flow | $34.3M | $24.0M | $10.3M | +43% |
| Free cash flow (OCF − capex) | $24.4M | $22.3M | $2.1M | +10% |
| Capital expenditures | $9.9M | $1.7M | $8.2M | +472% |
Questions
How much did Cronos Group's revenue grow quarter over quarter in Q3 2026?
Cronos Group's revenue rose $13.3M (+19%) from $70.6M in Q2 2026 to $83.9M in Q3 2026.
What drove Cronos Group's revenue change in Q3 2026?
Cannabis flower +$8.8M (+22%); Other revenues +$2.9M (+16%); Cannabis extracts +$1.7M (+12%).